Plus Therapeutics Inc. (PSTV) PT Lowered to $5 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts PSTV Hot Sheet
Price: $3.87 --0%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo lowered the price target on Plus Therapeutics Inc. (NASDAQ: PSTV) to $5.00 (from $5.50) while maintaining a Buy rating.
You May Also Be Interested In
- Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives
- JPMorgan Upgrades KCE Electronics PCL (KCE:TB) to Overweight
- Godrej Consumer Products Ltd. (GCPL:IN) PT Lowered to INR1,150 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
